Clinical Trials for Linnaeus Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Linnaeus Therapeutics

Clinical Trials (2)

NCT06624644
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
PHASE2/PHASE3Recruiting
135 participants
Started: Aug 6, 2025 · Completed: Feb 28, 2031
4 conditions2 sponsors7 locations
NCT04130516
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and with Pembrolizumab
PHASE1/PHASE2Recruiting
200 participants
Started: Oct 21, 2019 · Completed: Dec 15, 2027
1 condition2 sponsors10 locations